Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells

Author:

Schlosshauer Peter W.,Li Wei,Lin Kai-Ti,Chan Joseph L.-K.,Wang Lu-Hai

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference56 articles.

1. Focus on epithelial ovarian cancer;Ozols;Cancer Cell.,2004

2. Phase II trial of oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy;Sundar;Gynecol. Oncol.,2004

3. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer;Lafky;Biochim. Biophys. Acta,2008

4. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors;Steffensen;Int. J. Oncol.,2008

5. HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary;Ross;Am. J. Clin. Pathol.,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3